Dimitris Moulavasilis is the Chief Executive Officer of M42’s Global Patient Care platform, a central component of M42’s mission to transform healthcare on a global scale. With over 30 years of international experience in healthcare services and medical technology, Dimitris is known for driving innovation and excellence across the industry.
Under his leadership, the Global Patient Care platform has integrated M42’s UAE and international healthcare assets, consisting of 480 clinics across 26 countries, and serving 15 million patients annually. The platform delivers comprehensive healthcare services, including Renal Care, Outpatient and Chronic Disease Management, Diagnostics, Women's & Children's Health, Specialty Surgery, and Long-Term Care.
Prior to M42 Dimitris served as CEO of Diaverum the leading global renal care provider since 2018, spearheading major digital transformation initiatives, focusing on digitizing clinical workflows and integrating machine learning technologies to enhance healthcare teams' ability to provide high-quality renal care at scale. Before this, he was the Group Chief Executive Officer at Affidea, a leading European provider of imaging, outpatient, and cancer care services, where he led the company from 2012 to 2018. Earlier in his career, Dimitris held senior sales management roles at GE Healthcare, specializing in ultrasound systems and medical imaging devices.
A passionate advocate for digital healthcare transformation, Dimitris is committed to leveraging AI and technology to democratize and revolutionize healthcare, ensuring high-quality, personalized care is accessible to all.
